BlackRock Health Sciences Trust (BME) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.00x

BlackRock Health Sciences Trust (BME) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $5.09 Million. Check how high is BlackRock Health Sciences Trust's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$0.00
Capex + Investments

Operating Cash Flow

$5.09 Million
USD

Capital Expenditures

$0.00
USD

BlackRock Health Sciences Trust Cash Flow Reinvestment Rate (2006–2024)

Historical reinvestment intensity for BlackRock Health Sciences Trust across 10 annual periods. Explore BlackRock Health Sciences Trust long-term investment allocation to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for BlackRock Health Sciences Trust (2006–2024)

Year-by-year capital reinvestment analysis for BlackRock Health Sciences Trust. For live market cap and broader valuation context, see BME market cap overview.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2024 0.00x $0.00 $65.52 Million $0.00 ▼ -100.0%
2023 0.00x $3.00 $32.02 Million $3.00
2018 0.00x $0.00 $2.05 Million $0.00
2016 0.00x $0.00 $2.01 Million $0.00
2015 0.00x $0.00 $1.28 Million $0.00
2014 0.00x $0.00 $115.30 Million $0.00
2013 0.00x $0.00 $17.57 Million $0.00
2012 0.00x $0.00 $16.44 Million $0.00
2007 0.00x $0.00 $36.61 Million $0.00
2006 0.00x $0.00 $24.58 Million $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow